Alder BioPharmaceuticals (ALDR) Priced

Developing antibodies to prevent migraine and treat rheumatoid arthritis.

Health Care - Biotechnology

IPO Performance
Latest Trade $21.78 0.00 (0.0%)
First Day Return 0.3%
Return from IPO 117.8%
 
Alder BioPharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 03/19/2014
Offer Price $10.00
Price Range $13.00 - $15.00
Offer Shares (mm) 8.0
Deal Size ($mm) 80
 
IPO Data
IPO Date 05/07/2014
Offer Price $10.00
Price Range $13.00 - $15.00
Offer Shares (mm) 8.0
Deal Size ($mm) $80
 
Underwriters
more
Business Overview
Developing antibodies to prevent migraine and treat rheumatoid arthritis.
Developing antibodies to prevent migraine and treat rheumatoid arthritis.
more
Company Data
Headquarters Bothell, WA
Founded 2002
Employees 77
Website www.alderbio.com
 

Performance vs. IPO Index (IPOUSA)